Grant: Discovery Grants Program - Individual
Université d'Ottawa
$36,000.00
Contrast Agents & Radiotracers As Activity-Based Sensors of Faulty Metabolism
EF 2023-24
Résumé
The ability to image the biochemical changes deep inside our bodies as we progress from being healthy to being sick has revolutionized our understanding of disease. The combination of innovations in chemistry and physics has enabled this revolution, advancing both the machines and injectable chemical probes required to generate these images. One way to continue to advance our imaging capabilities is through novel chemistry controlling the physical properties of these imaging systems in new ways. The current proposal will generate new chemical approaches allowing multiple biochemical targets to be tracked at one time by Magnetic Resonance Imaging. New assemblies of nanoparticles that will manipulate light to allow the biochemistry of our blood vessels to be evaluated using Optical Coherence Tomography will also be developed. Another way to advance our imaging capabilities is to rethink how we pick what we image. Selection has largely taken a reductionist approach (e.g. expression levels of one protein), falling behind paralleled fields of biochemistry. The value of a systems-based approach has been accepted in biochemistry, which looks at the net outcome of dynamic biochemical events to define the health of the cell or tissue. To this end, we will develop a new imaging agent to report on this `net outcome' for the use of Vitamin B6, an essential enabler of more than 140 biochemical reactions. Overall, the proposed work seeks to expand the functionality of imaging with new chemical approaches, and to redefine what constitutes value in an imaging biomarker. The outcomes of this proposal are positioned to impact imaging science and our molecular understanding of disease in the short-term. New chemical platforms will enable imaging chemists and biochemists globally to evaluate of sets of biochemical targets not previously possible. Disease processes are the net outcomes of concerted biochemical pathways, and the chemistry proposed would make key information about the interaction of proteins in space and time uniquely accessible. In the longer-term, these chemical platforms for imaging probe development can have impact on clinical imaging, as all of the imaging approaches targeted herein are used daily on humans. As a result, the proposed work could positively impact imaging-based diagnostics and improve the health of Canadians. Importantly, the proposed training program will also make strides to overcome barriers to the inclusion of under-represented groups in science. With a partnership between uOttawa and a local community organization supporting Inuit families in Ottawa, we will develop science outreach providing a broad range of scientific programming tied to Inuit culture for Inuit youth.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2021-03387
Name nom
Shuhendler, Adam
Department département
Chemistry - Chimie
Organization id
28
Institution établissement
Université d'Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5408
Research subject group en
Biochemistry
Research subject group fr
Metabolism
Research subject en
Biochimie
Research subject fr
Métabolisme
Application title
Contrast Agents & Radiotracers As Activity-Based Sensors of Faulty Metabolism
Keyword
Chemical Exchange Saturation Transfer; Kinase Activity; Magnetic Resonance Imaging; Molecular Imaging Probe Development; Multiplexed Molecular MRI; Nanoclusters; Optical Coherence Tomography; Positron Emission Tomography; Protease Activity; Radiofluorination
Application summary
The ability to image the biochemical changes deep inside our bodies as we progress from being healthy to being sick has revolutionized our understanding of disease. The combination of innovations in chemistry and physics has enabled this revolution, advancing both the machines and injectable chemical probes required to generate these images. One way to continue to advance our imaging capabilities is through novel chemistry controlling the physical properties of these imaging systems in new ways. The current proposal will generate new chemical approaches allowing multiple biochemical targets to be tracked at one time by Magnetic Resonance Imaging. New assemblies of nanoparticles that will manipulate light to allow the biochemistry of our blood vessels to be evaluated using Optical Coherence Tomography will also be developed. Another way to advance our imaging capabilities is to rethink how we pick what we image. Selection has largely taken a reductionist approach (e.g. expression levels of one protein), falling behind paralleled fields of biochemistry. The value of a systems-based approach has been accepted in biochemistry, which looks at the net outcome of dynamic biochemical events to define the health of the cell or tissue. To this end, we will develop a new imaging agent to report on this `net outcome' for the use of Vitamin B6, an essential enabler of more than 140 biochemical reactions. Overall, the proposed work seeks to expand the functionality of imaging with new chemical approaches, and to redefine what constitutes value in an imaging biomarker. The outcomes of this proposal are positioned to impact imaging science and our molecular understanding of disease in the short-term. New chemical platforms will enable imaging chemists and biochemists globally to evaluate of sets of biochemical targets not previously possible. Disease processes are the net outcomes of concerted biochemical pathways, and the chemistry proposed would make key information about the interaction of proteins in space and time uniquely accessible. In the longer-term, these chemical platforms for imaging probe development can have impact on clinical imaging, as all of the imaging approaches targeted herein are used daily on humans. As a result, the proposed work could positively impact imaging-based diagnostics and improve the health of Canadians. Importantly, the proposed training program will also make strides to overcome barriers to the inclusion of under-represented groups in science. With a partnership between uOttawa and a local community organization supporting Inuit families in Ottawa, we will develop science outreach providing a broad range of scientific programming tied to Inuit culture for Inuit youth.